Tag Archives: pd-l1 expression

Nivolumab Improves pCR in High-Risk ER-Positive, HER2-Negative Breast Cancer Patients with Higher PD-L1 Expression

Nivolumab improves pCR rates in high-risk ER+, HER2- breast cancer patients with higher PD-L1 expression,.....Read more